Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration

• Status: Recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess Ketamine as an adjuvant to Branchial Plexus Blockade.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National and Kapodistrian University of Athens
• Treatments: Ketamine; Ropivacaine

Criteria

Inclusion Criteria:

• BMI 20-35

• ASA score I, II, III

Exclusion Criteria:

• Mental disorder

• Peripheral neuropathy

• Severe hepatic or renal disease

• Gastrointestinal bleeding history